Research programme: neuropeptide S receptor modulators - Pfizer
Alternative Names: WYE-198232Latest Information Update: 16 Jul 2016
At a glance
- Originator Pfizer
- Class Small molecules
- Mechanism of Action Neuropeptide receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Anxiety-disorders in USA
- 07 Feb 2011 Early research in Anxiety disorders in USA (unspecified route)
- 07 Feb 2011 Pharmacodynamics data from in vitro tests in Anxiety disorders presented at the 40th Annual Meeting of the Society for Neuroscience (SfN-2010)